DUrable Polymer-based STent CHallenge of Promus Element Versus ReSolute Integrity (DUTCH PEERS): Randomized Multicenter Trial in All Comers Population Treated Within Eastern NeThErlands-2 (TWENTE-2)
Phase of Trial: Phase IV
Latest Information Update: 30 Aug 2017
At a glance
- Drugs Everolimus (Primary) ; Zotarolimus (Primary)
- Indications Coronary artery disease; Coronary artery restenosis
- Focus Therapeutic Use
- Acronyms DUTCH-PEERS/TWENTE-2
- 30 Aug 2017 Results assessing 4-year clinical safety and efficacy, presented at the ESC Congress 2017: Annual Congress of the European Society of Cardiology.
- 03 Nov 2013 Results published in the Lancet.
- 31 Oct 2013 Status changed from active, no longer recruiting to completed.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History